BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 16013903)

  • 21. The Texas Children's Medication Algorithm Project: report of the Texas Consensus Conference Panel on Medication Treatment of Childhood Major Depressive Disorder.
    Hughes CW; Emslie GJ; Crismon ML; Wagner KD; Birmaher B; Geller B; Pliszka SR; Ryan ND; Strober M; Trivedi MH; Toprac MG; Sedillo A; Llana ME; Lopez M; Rush AJ
    J Am Acad Child Adolesc Psychiatry; 1999 Nov; 38(11):1442-54. PubMed ID: 10560232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of manic phases of bipolar disorder: critical synthesis of international guidelines].
    Geoffroy PA; Bellivier F; Henry C
    Encephale; 2014 Sep; 40(4):330-7. PubMed ID: 24513018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mixed states in bipolar and major depressive disorders: systematic review and quality appraisal of guidelines.
    Verdolini N; Hidalgo-Mazzei D; Murru A; Pacchiarotti I; Samalin L; Young AH; Vieta E; Carvalho AF
    Acta Psychiatr Scand; 2018 Sep; 138(3):196-222. PubMed ID: 29756288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder.
    Pliszka SR; Crismon ML; Hughes CW; Corners CK; Emslie GJ; Jensen PS; McCRACKEN JT; Swanson JM; Lopez M;
    J Am Acad Child Adolesc Psychiatry; 2006 Jun; 45(6):642-657. PubMed ID: 16721314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment guidelines: current and future management of bipolar disorder.
    Goldberg JF
    J Clin Psychiatry; 2000; 61 Supp 13():12-8. PubMed ID: 11153806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential efficacy of olanzapine and lithium in preventing manic or mixed recurrence in patients with bipolar I disorder based on number of previous manic or mixed episodes.
    Ketter TA; Houston JP; Adams DH; Risser RC; Meyers AL; Williamson DJ; Tohen M
    J Clin Psychiatry; 2006 Jan; 67(1):95-101. PubMed ID: 16426094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Florida Best Practice Psychotherapeutic Medication Guidelines for Adults With Major Depressive Disorder.
    McIntyre RS; Suppes T; Tandon R; Ostacher M
    J Clin Psychiatry; 2017 Jun; 78(6):703-713. PubMed ID: 28682531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Texas Children's Medication Algorithm Project: Report of the Texas Consensus Conference Panel on Medication Treatment of Childhood Attention-Deficit/Hyperactivity Disorder. Part I. Attention-Deficit/Hyperactivity Disorder.
    Pliszka SR; Greenhill LL; Crismon ML; Sedillo A; Carlson C; Conners CK; McCracken JT; Swanson JM; Hughes CW; Llana ME; Lopez M; Toprac MG
    J Am Acad Child Adolesc Psychiatry; 2000 Jul; 39(7):908-19. PubMed ID: 10892234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aripiprazole alone or in combination for acute mania.
    Brown R; Taylor MJ; Geddes J
    Cochrane Database Syst Rev; 2013 Dec; (12):CD005000. PubMed ID: 24346956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Practitioner versus medication-expert opinion on psychiatric pharmacotherapy of mentally retarded patients with mental disorders.
    Patel NC; Crismon ML; Rush AJ; Frances A
    Am J Health Syst Pharm; 2001 Oct; 58(19):1824-9. PubMed ID: 11596698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Texas Medication Algorithm Project, phase 3 (TMAP-3): clinical results for patients with a history of mania.
    Suppes T; Rush AJ; Dennehy EB; Crismon ML; Kashner TM; Toprac MG; Carmody TJ; Brown ES; Biggs MM; Shores-Wilson K; Witte BP; Trivedi MH; Miller AL; Altshuler KZ; Shon SP;
    J Clin Psychiatry; 2003 Apr; 64(4):370-82. PubMed ID: 12716236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Letter to the Editor: CONVERGENCES AND DIVERGENCES IN THE ICD-11 VS. DSM-5 CLASSIFICATION OF MOOD DISORDERS.
    Cerbo AD
    Turk Psikiyatri Derg; 2021; 32(4):293-295. PubMed ID: 34964106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Texas Medication Algorithm Project, phase 3 (TMAP-3): rationale and study design.
    Rush AJ; Crismon ML; Kashner TM; Toprac MG; Carmody TJ; Trivedi MH; Suppes T; Miller AL; Biggs MM; Shores-Wilson K; Witte BP; Shon SP; Rago WV; Altshuler KZ;
    J Clin Psychiatry; 2003 Apr; 64(4):357-69. PubMed ID: 12716235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Texas Medication Algorithm Project Patient and Family Education Program: a consumer-guided initiative.
    Toprac MG; Rush AJ; Conner TM; Crismon ML; Dees M; Hopkins C; Rowe V; Shon SP
    J Clin Psychiatry; 2000 Jul; 61(7):477-86. PubMed ID: 10937605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The clinical management of bipolar disorder: a review of evidence-based guidelines.
    Connolly KR; Thase ME
    Prim Care Companion CNS Disord; 2011; 13(4):. PubMed ID: 22132354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Korean medication algorithm for bipolar disorder: second revision.
    Shin YC; Min KJ; Yoon BH; Kim W; Jon DI; Seo JS; Woo YS; Lee JG; Bahk WM
    Asia Pac Psychiatry; 2013 Dec; 5(4):301-8. PubMed ID: 23857877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Study on clozapine treatment at the Charles Perrens Hospital in Bordeaux, 15 years after its marketing].
    Mercier C; Bret P; Bret MC; Queuille E
    Encephale; 2009 Sep; 35(4):321-9. PubMed ID: 19748368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Texas Children's Medication Algorithm Project: Report of the Texas Consensus Conference Panel on Medication Treatment of Childhood Attention-Deficit/Hyperactivity Disorder. Part II: Tactics. Attention-Deficit/Hyperactivity Disorder.
    Pliszka SR; Greenhill LL; Crismon ML; Sedillo A; Carlson C; Conners CK; McCracken JT; Swanson JM; Hughes CW; Llana ME; Lopez M; Toprac MG
    J Am Acad Child Adolesc Psychiatry; 2000 Jul; 39(7):920-7. PubMed ID: 10892235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders: bipolar disorder summary.
    Malhi GS; Outhred T; Morris G; Boyce PM; Bryant R; Fitzgerald PB; Hopwood MJ; Lyndon B; Mulder R; Murray G; Porter RJ; Singh AB; Fritz K
    Med J Aust; 2018 Mar; 208(5):219-225. PubMed ID: 29540132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.